New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses.

about

New maresin conjugates in tissue regeneration pathway counters leukotriene D4-stimulated vascular responses.

Item

http://www.wikidata.org/entity/Q52681249

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

New maresin conjugates in tiss ...... stimulated vascular responses.

@en

New maresin conjugates in tiss ...... stimulated vascular responses.

@nl

type

Item

label

New maresin conjugates in tiss ...... stimulated vascular responses.

@en

New maresin conjugates in tiss ...... stimulated vascular responses.

@nl

prefLabel

New maresin conjugates in tiss ...... stimulated vascular responses.

@en

New maresin conjugates in tiss ...... stimulated vascular responses.

@nl

P1476

New maresin conjugates in tiss ...... stimulated vascular responses.

@en

P2093

Ana R Rodriguez

http://www.w3.org/2001/XMLSchema#string

Bernd W Spur

http://www.w3.org/2001/XMLSchema#string

Charles N Serhan

http://www.w3.org/2001/XMLSchema#string

Ian R Riley

http://www.w3.org/2001/XMLSchema#string

Jesmond Dalli

http://www.w3.org/2001/XMLSchema#string

Nan Chiang

http://www.w3.org/2001/XMLSchema#string

P2860

Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses

Identification and Actions of a Novel Third Maresin Conjugate in Tissue Regeneration: MCTR3

D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.

Ciona intestinalis as a model for cardiac development.

Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection.

Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials.

Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.

Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.

Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques.

P304

fj201701493R

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.201701493R

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-02-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29490167

http://www.w3.org/2001/XMLSchema#string

P932

5998978

http://www.w3.org/2001/XMLSchema#string